Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9167 |
High Similarity |
NPD3749 |
Approved |
0.8742 |
High Similarity |
NPD1243 |
Approved |
0.8733 |
High Similarity |
NPD2344 |
Approved |
0.8726 |
High Similarity |
NPD7411 |
Suspended |
0.871 |
High Similarity |
NPD920 |
Approved |
0.8701 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8616 |
High Similarity |
NPD7819 |
Suspended |
0.8598 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8581 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8581 |
High Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8571 |
High Similarity |
NPD7075 |
Discontinued |
0.8509 |
High Similarity |
NPD7768 |
Phase 2 |
0.8506 |
High Similarity |
NPD2309 |
Approved |
0.85 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8497 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8452 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8447 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8431 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8402 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8385 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8366 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8366 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8364 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8323 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8323 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8313 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8258 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.825 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8235 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8235 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8228 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8228 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8228 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8212 |
Intermediate Similarity |
NPD1240 |
Approved |
0.821 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8193 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8165 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8133 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8129 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8118 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8105 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8098 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8095 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8086 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8079 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8072 |
Intermediate Similarity |
NPD919 |
Approved |
0.8068 |
Intermediate Similarity |
NPD4287 |
Approved |
0.8065 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8061 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8061 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.805 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8049 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8023 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.8013 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7962 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7953 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7953 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.795 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7949 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7939 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7907 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7907 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7892 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7892 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7867 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7862 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7843 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7836 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7836 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7836 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD1247 |
Approved |
0.775 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7727 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7719 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7719 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7719 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7719 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7683 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7679 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7673 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7667 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7657 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7643 |
Intermediate Similarity |
NPD6651 |
Approved |
0.764 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7632 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7627 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7613 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7597 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7576 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7561 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.756 |
Intermediate Similarity |
NPD6280 |
Approved |
0.756 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7557 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7556 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7547 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7514 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD5404 |
Approved |
0.75 |
Intermediate Similarity |
NPD5408 |
Approved |
0.75 |
Intermediate Similarity |
NPD6100 |
Approved |
0.75 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5406 |
Approved |
0.75 |
Intermediate Similarity |
NPD6099 |
Approved |
0.75 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7486 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7483 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7472 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7468 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7438 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.743 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7423 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7405 |
Intermediate Similarity |
NPD943 |
Approved |
0.7403 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7403 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7403 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7389 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7389 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7377 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7358 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7358 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7326 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.732 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7312 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7296 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7289 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD411 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7268 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7263 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7257 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.725 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7247 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7209 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7209 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7175 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD37 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7134 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7134 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7134 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7126 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7124 |
Intermediate Similarity |
NPD17 |
Approved |
0.712 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.712 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7112 |
Intermediate Similarity |
NPD3269 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7101 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7098 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7093 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7093 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7086 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7086 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7031 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7031 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7031 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7031 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7031 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7031 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7031
|
Intermediate Similarity |
NPD6782 |
Approved |